Genefar

Genfar is a leading pharmaceutical company based in Colombia that specializes in the development, manufacturing, and commercialization of affordable generic medicines across Latin America. Founded in 1967, the company has established a significant presence in the Andean region, including Colombia, Ecuador, and Peru, offering a broad portfolio of over 140 molecules across multiple therapeutic classes. Genfar was acquired by Sanofi in 2012 to bolster its emerging markets presence and was subsequently acquired by the Brazilian pharmaceutical giant Eurofarma in 2023. Today, it operates as a key brand within Eurofarma's international portfolio, focusing on expanding access to high-quality essential medicines in retail and institutional markets.